VBI (4170.TWO)
TWD 12.35
(-0.4%)
TWD 12.35
(-0.4%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 452.1 Million TWD | -2.95% |
| 2022 | 465.82 Million TWD | -5.44% |
| 2021 | 492.64 Million TWD | 33.48% |
| 2020 | 369.08 Million TWD | -5.12% |
| 2019 | 389 Million TWD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 438.24 Million TWD | 0.0% |
| 2024 Q1 | 438.24 Million TWD | -3.07% |
| 2023 Q3 | 452.1 Million TWD | -1.83% |
| 2023 Q2 | 460.52 Million TWD | 0.0% |
| 2023 Q1 | 460.52 Million TWD | -1.14% |
| 2023 FY | 452.1 Million TWD | -2.95% |
| 2023 Q4 | 452.1 Million TWD | 0.0% |
| 2022 Q4 | 465.82 Million TWD | 0.0% |
| 2022 Q3 | 465.82 Million TWD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | 128.04 Million TWD | -253.075% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 2.9 Billion TWD | 84.415% |
| Level Biotechnology Inc. | 822.67 Million TWD | 45.045% |
| Sagittarius Life Science Corp | 664.72 Million TWD | 31.986% |
| NeoCore Technology Co., Ltd. | 548.74 Million TWD | 17.612% |
| TaiMed Biologics Inc. | 3.89 Billion TWD | 88.39% |
| GlycoNex Incorporation | 1.55 Billion TWD | 70.885% |
| GeneReach Biotechnology Corp. | 1.17 Billion TWD | 61.561% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 748.57 Million TWD | 39.605% |
| SynCore Biotechnology Co.,Ltd | 378.36 Million TWD | -19.489% |
| Genomics BioSci & Tech. Co.,Ltd. | 1.13 Billion TWD | 60.127% |
| Visgeneer Inc. | 397.17 Million TWD | -13.829% |
| Mycenax Biotech Inc. | 3.77 Billion TWD | 88.009% |
| Sunmax Biotechnology Co., Ltd. | 2.15 Billion TWD | 79.06% |
| G&E Herbal Biotechnology Co., Ltd. | 883.09 Million TWD | 48.805% |
| Neith Corporation | 192.15 Million TWD | -135.282% |
| Medigen Vaccine Biologics Corporation | 6.09 Billion TWD | 92.58% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 73.55 Million TWD | -514.62% |
| Enimmune corporation | 604.82 Million TWD | 25.251% |
| TaiRx, Inc. | 833.74 Million TWD | 45.775% |
| CHO Pharma, Inc. | 3.08 Billion TWD | 85.35% |
| EirGenix Inc. | 11.16 Billion TWD | 95.95% |
| BioLASCO Taiwan Co., Ltd. | 573.13 Million TWD | 21.118% |
| Sunny Pharmtech Inc. | 1.71 Billion TWD | 73.598% |
| Lin BioScience, Inc. | 3.59 Billion TWD | 87.43% |
| BioGend Therapeutics Co., Ltd. | 1.05 Billion TWD | 56.962% |
| Feng Chi Biotech Corp. | 301.03 Million TWD | -50.184% |
| Bio Preventive Medicine Corp. | 264.65 Million TWD | -70.826% |
| Lukas Biomedical Inc. | 441.19 Million TWD | -2.473% |
| RBC Bioscience Corporation | 753.79 Million TWD | 40.023% |
| BiOptic Inc. | 613.77 Million TWD | 26.341% |
| BRIM Biotechnology, Inc. | 1.77 Billion TWD | 74.582% |
| Shine-On BioMedical Co.,Ltd. | 1.15 Billion TWD | 61.016% |
| Great Novel Therapeutics Biotech & Medicals | 644.84 Million TWD | 29.89% |
| Syngen Biotech Co.,Ltd. | 3.1 Billion TWD | 85.445% |
| Advagene Biopharma Co., Ltd. | 147.93 Million TWD | -205.611% |
| NaviFUS Corp. | 490.53 Million TWD | 7.835% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 1.22 Billion TWD | 63.115% |
| Sinew Pharma Inc. | 1.36 Billion TWD | 66.839% |
| Andros Pharmaceuticals Co.,Ltd | 529.14 Million TWD | 14.56% |
| Greenyn Biotechnology Co., Ltd | 1.16 Billion TWD | 61.072% |
| Lumosa Therapeutics Co., Ltd. | 1.65 Billion TWD | 72.704% |
| AP Biosciences Inc | 890.75 Million TWD | 49.245% |
| Medigen Biotechnology Corp. | 8.52 Billion TWD | 94.698% |
| 3D Global Biotech Inc. | 324.14 Million TWD | -39.474% |
| Pharmosa Biopharm Inc. | 1.33 Billion TWD | 66.1% |
| Intech Biopharm Corporation | 2.71 Billion TWD | 83.324% |
| Oneness Biotech Co., Ltd. | 15.36 Billion TWD | 97.057% |
| Eusol Biotech Co.,Ltd. | 410.25 Million TWD | -10.199% |
| TWi Biotechnology, Inc. | 396.85 Million TWD | -13.922% |
| Ever Supreme Bio Technology Co., Ltd | 2.07 Billion TWD | 78.222% |
| TCI GENE Inc. | 1.16 Billion TWD | 61.224% |
| MegaPro Biomedical Co., Ltd | 294.58 Million TWD | -53.473% |
| Senhwa Biosciences, Inc. | 1.36 Billion TWD | 66.838% |
| Taiwan Bio Therapeutics Co., Ltd | 941.76 Million TWD | 51.994% |
| NatureWise Biotech & Medicals Corporation | 698.45 Million TWD | 35.271% |
| PharmaEngine, Inc. | 3.95 Billion TWD | 88.566% |
| Savior Lifetec Corporation | 3.82 Billion TWD | 88.173% |
| TaiGen Biopharmaceuticals Holdings Limited | 1.22 Billion TWD | 63.239% |
| OBI Pharma, Inc. | 5.6 Billion TWD | 91.932% |
| Meribank Biotech Co., Ltd | 1.06 Billion TWD | 57.43% |
| Acepodia, Inc. | 6.81 Billion TWD | 93.37% |
| Caliway Biopharmaceuticals Co., Ltd. | 3.82 Billion TWD | 88.185% |